Biondini M, Kiepas A, El-Houjeiri L, Annis MG, et al. HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin. Oncogene 2022 Feb 2. pii: 10.1038/s41388-022-02206.
PMID: 35110681